Monitoring anti-HIV medicines: what is the FDA's role?
Mirken
B
B
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D017277:Drug Approval; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D011358:Product Surveillance, Postmarketing; D014481:United States; D014486:United States Food and Drug Administration / Q000458:organization & administration*
D019380:Anti-HIV Agents